Better Quality of Life for People Living with Diabetes Through Validated Innovative Artificial Intelligence Applications
About Melissa
MELISSA aims to innovate diabetes treatment and care for people with insulin-treated diabetes through the development of a clinically validated, efficient and cost-effective Artificial Intelligence-based digital diabetes management solution. This will contribute to every person with insulin-treated diabetes receiving tailored treatment and care according to their individual needs, habits and evolution resulting in a better quality of life.
Start Date
1 June 2022
1 June 2022
Duration
4 Years
4 Years
Budget
approx. 8 Mil. €
approx. 8 Mil. €
12 Partners
7 Countries
7 Countries
News & Events
Follow us
on Twitter
Follow us
on LinkedIn